REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $630,801 | +141.4% | 24,923 | +207.2% | 0.00% | +200.0% |
Q1 2023 | $261,288 | +2.6% | 8,112 | -41.2% | 0.00% | 0.0% |
Q4 2022 | $254,674 | -87.9% | 13,796 | -82.2% | 0.00% | -90.0% |
Q3 2022 | $2,097,000 | +33.1% | 77,670 | +24.1% | 0.01% | 0.0% |
Q3 2020 | $1,575,000 | +94.7% | 62,599 | +89.0% | 0.01% | +66.7% |
Q2 2020 | $809,000 | – | 33,126 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |